Engaging communities with clinical trials in Malawi.
Community Meetings. Community meetings are publicly held forums, allowing anyone who is a member of a local group or a resident to participate. Before conducting community meetings, one must ...
Articles
Fighting Typhoid in Kathmandu: OUCRU Nepal’s Community-Centered Approach to Research and Public Engagement
Typhoid fever continues to pose a significant public health challenge across many low- and middle-income countries, including Nepal. Caused by the Salmonella typhi bacterium, the disease is primarily transmitted ...
Short birth spacing and its impact on maternal and child health in India with urban-rural variation: An epidemiological study using the National Family Health Survey Data
This study aims to assess the prevalence of short birth spacing (SBS) in association with demographic and socio-economic factors in India with special reference to maternal and child health. This study ...
Barriers to utilization of anti-retroviral therapy among HIV positive pregnant women in Birnin Kebbi, North West Nigeria
This study investigates barriers to the utilization of antiretroviral therapy among HIV-positive pregnant women in Birnin Kebbi, North West Nigeria. This study concludes that interventions focusing on community education to reduce ...
Structural racism and perinatal mental health - The role of racialized economic segregation
The objective of the study was to estimate associations between the index of concentration at the extremes (ICE) -a proxy for anti-Black structural racism- and hospital-reported perinatal mental disorders (PMD). Findings reveal ...
News
CEPI launches its first ever Biosecurity Request for Proposals (RfP)
Biosafety and biosecurity capacity strengthening in support of the 100 Days Mission RfP. Deadline for application: 30 July 2025
CEPI hopes to identify a group of implementing partners who can help achieve its Biosecurity Strategy. CEPI is looking for partners who can support different types of activities, across diverse geographic settings, related to its biosecurity objectives Read more
CEPI launches a Call for Proposal for innovative analytical technologies to improve vaccine manufacturing speed and equitable access
Deadline for application: 1 May 2026. An application may be submitted at any time; the review process will involve quarterly reviews throughout the 12-month application period
CEPI has announced a funding opportunity to develop innovative analytical technologies for vaccines. The goal is to reduce vaccine development, manufacturing, and release times; lower costs, improve equitable deployment in Low to Middle-Income Countries, and enhance analytical insights for vaccines. Read more
Scientists at Denmark’s AdaptVac lead pioneering research to develop an all-in-one vaccine against deadly filoviruses
CEPI and the EU’s Horizon Europe programme are funding the development of a single vaccine to protect against Ebola viruses, Marburg, and other filoviruses
A global consortium led by Danish biotech AdaptVac is developing a vaccine that combines AI-designed immunogens, components that trigger immune response, with AdaptVac’s virus-like particle platform, which mimics real viruses to safely stimulate immunity against multiple deadly filoviruses. Read more
Overcoming CMC, Manufacturing, and Supply Chain Challenges in Vaccine Production: A Review of Efforts in the Global South, with a Focus on Africa
By Vishal Sonje and Valerie Chambard, published in Vaccine Insights on 6 June 2025
This article delves into the challenges and potential solutions, complemented by several case studies, concerning the establishment of robust and resilient vaccine manufacturing and supply chains in low- and middle-income countries Read more
SPEAC's Companion Guide for Single Organ Cutaneous Vasculitis
SPEAC has released a comprehensive Companion Guide for the Brighton Collaboration Case Definition of Single Organ Cutaneous Vasculitis (SOCV)
SPEAC announces the release of a comprehensive Companion Guide for the Brighton Collaboration Case Definition of Single Organ Cutaneous Vasculitis (SOCV). This new resource combines a wealth of tools and guidance to standardize vaccine safety assessments and pharmacovigilance efforts worldwide. Read more
CEPI has launched the Research Preparedness Program (RPP)
The RPP will support both advanced-stage clinical development of CEPI’s portfolio vaccines against priority diseases and the 100 Days Mission
The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more
| Older News Here |
Resources
Pandemic Preparedness & Response Playbook
In collaboration with TGHN, CEPI created this playbook to bring together the many tools, resources and materials generated for pandemic preparedness and response from the COVID-19 pandemic. The first (Regulatory) chapter is now available.
TRANSVAC Academy Training Courses
TRANSVAC Academy offers training modules in vaccine R&D including grant management, statistics, cytometry and advanced process development. CEPI funded scholarships are provided to selected applicants from LMICs.
SPEAC: THE SAFETY PLATFORM FOR EMERGENCY VACCINES
SPEAC is a CEPI and Brighton Collaboration project. SPEAC provides vaccine safety tools, resources, and expertise throughout the vaccine development process to enhance safety and build confidence in vaccines.
Monitoring Vaccine Performance against SARS CoV-2 Variants
The IVAC COVID-19 Vaccine Effectiveness Project (a CEPI- funded global systematic review which also includes neutralization capacity) outputs are publicly available on VIEWhub to assist all policy makers
International Pandemic Preparedness Secretariat
The IPPS serves to join up relevant states, the private sector, and global health institutions in support of the 100 Days Mission, across vaccines, therapeutics, and diagnostics. It performs a global annual progress review related to the 100 DM which feeds into implementation reports.
Vaccine Development
Process Maps
The UK Vaccine R&D Network has developed vaccine development maps to show key stages in human and veterinary vaccines development up to Phase III clinical trials. These process maps and associated case studies provide support in understanding key stages in vaccine development and where bottlenecks could cause delays.
